Ustekinumab (Brand name: Stelara) a human monoclonal antibody which blocks the p40 subunit of IL-12 and IL-23 is the new biologics approved for the treatment of moderate to severe psoriasis. Stelara is new biologics for psoriasis indicated for those who ...
DermaTalk Latest Articles
Biologics For Psoriasis
There have been many discoveries and research in the management of moderate and severe psoriasis for last 2-3 decades. Better understanding about the pathogenesis of psoriasis has led to advance in better treatment options for psoriasis. Traditional systemic treatment for ...